Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

Author:

Ellingson Benjamin M12ORCID,Abrey Lauren E3,Nelson Sarah J4,Kaufmann Timothy J5,Garcia Josep3,Chinot Olivier6,Saran Frank7,Nishikawa Ryo8,Henriksson Roger9,Mason Warren P10,Wick Wolfgang11,Butowski Nicholas12,Ligon Keith L13,Gerstner Elizabeth R14,Colman Howard15,de Groot John16,Chang Susan12,Mellinghoff Ingo17,Young Robert J17,Alexander Brian M18,Colen Rivka19,Taylor Jennie W12,Arrillaga-Romany Isabel14,Mehta Arnav12,Huang Raymond Y20,Pope Whitney B2,Reardon David21,Batchelor Tracy14,Prados Michael12,Galanis Evanthia2223,Wen Patrick Y21,Cloughesy Timothy F24

Affiliation:

1. UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, California, USA

2. Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA

3. F. Hoffman-La Roche, Ltd, Basel, Switzerland

4. Department of Radiology and Biomedical Imaging, University of California San Francisco (UCSF), San Francisco, California, USA

5. Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA

6. Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, Marseille, France

7. The Royal Marsden NHS Foundation Trust, Sutton, UK

8. Saitama Medical University, Saitama, Japan

9. Regional Cancer Center Stockholm, Stockholm, Sweden and Umeå University, Umeå, Sweden

10. Princess Margaret Hospital, Toronto, Ontario, Canada

11. Clinical Cooperation Unit Neurooncology, German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany

12. Department of Neurosurgery, University of California San Francisco, San Francisco, California, USA

13. Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

14. Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

15. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

16. Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

17. Memorial Sloan Kettering Cancer Center, New York, New York, USA

18. Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

19. Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

20. Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts, USA

21. Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

22. Department of Molecular Medicine, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA

23. Department of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA

24. UCLA Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA

Funder

American Cancer Society

NIH/NCI

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3